
XTXXF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for XTXXF and 80,000+ other tickers.
See exactly how XTXXF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for XTXXF and 80,000+ other tickers.
Adastra Holdings Ltd. functions as a company specializing in cannabis extraction and processing. It offers services such as analytical testing for cannabis and comprehensive processing solutions. The firm supports authorized cannabis and hemp growers with its processing expertise and supplies concentrated cannabis derivatives to qualified business-to-business clients both domestically in Canada and worldwide. The company, which was established in 1987 and is headquartered in Langley, Canada, was formerly known as Phyto Extractions Inc. until it rebranded as Adastra Holdings Ltd. in September 2021.

Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") is pleased to announce that Calum Maschi has been appointed as a director of the Company in place of Jonathan Edwards who has resigned as a director, effective April 30, 2026.

Langley, British Columbia--(Newsfile Corp. - April 29, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands with a focus on product innovation and commercialization for adult-use and medical markets, announces today that Paul Morgan has tendered his resignation as a director of the Company effective as of April 28, 2026.

Langley, British Columbia--(Newsfile Corp. - March 2, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company") announces that Adastra Labs Inc. ("Adastra Labs"), a wholly-owned subsidiary of the Company, has entered into an asset purchase agreement dated February 27, 2026 with an arm's length purchaser (the "Purchaser"), pursuant to which Adastra Labs has agreed to sell certain cryoethanol and hydrocarbon extraction and processing equipment as well as packaging and labelling machinery (collectively, the "Assets") to the Purchaser in consideration for $166,225 (the "Sale").

Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has completed the sale of all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd.